Ligand profile
ZINC55250732
Virtual-screening candidate from ZINC.
Bound to: KP13_00203 — putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate coenzyme A ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC55250732- UniProt (similar protein)
P22557- Tanimoto
- 1.000
- Target protein
- KP13_00203
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 23.6
- −1 ≤ LogP ≤ 5 1.91
- MW ≤ 500 Da 238.4
- LogP ≤ 5 1.91
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 23.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(C)N1CCN(C(=O)c2cccs2)CC1CC(C)N1CCN(C(=O)c2cccs2)CC1
InChI=1S/C12H18N2OS/c1-10(2)13-5-7-14(8-6-13)12(15)11-4-3-9-16-11/h3-4,9-10H,5-8H2,1-2H3InChI=1S/C12H18N2OS/c1-10(2)13-5-7-14(8-6-13)12(15)11-4-3-9-16-11/h3-4,9-10H,5-8H2,1-2H3
ZEVVAPJSMUTCRY-UHFFFAOYSA-NZEVVAPJSMUTCRY-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- NUY
- Homolog
- P22557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC55250732 →
- ZINC ZINC20 ZINC55250732 →
- UniProt UniProt P22557 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC55250732”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00203.
PDB 33
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).